Cargando…
Implanted islet mass influences the effects of dipeptidyl peptidase-IV inhibitor LAF237 on transplantation outcomes in diabetic mice
BACKGROUND: Previous studies showed inconsistent Results of the effects of dipeptidyl peptidase (DPP)-IV inhibitors on syngeneic mouse islet transplantation. We hypothesized that the implanted islet numbers are critical for the effects of DPP-IV inhibitors on the outcomes of transplantation. METHODS...
Autores principales: | Juang, Jyuhn-Huarng, Chen, Chen-Yi, Kao, Chen-Wei, Huang, Yu-Wen, Chiu, Tai-Yu, Chen, Chiung-Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chang Gung University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068567/ https://www.ncbi.nlm.nih.gov/pubmed/35300943 http://dx.doi.org/10.1016/j.bj.2020.10.002 |
Ejemplares similares
-
Effects of Dipeptidyl Peptidase-4 Inhibition with MK-0431 on Syngeneic Mouse Islet Transplantation
por: Juang, Jyuhn-Huarng, et al.
Publicado: (2014) -
Islets and Glucose Homeostasis
por: Chang, Tien-Jyun, et al.
Publicado: (2015) -
3-D Imaging Reveals Participation of Donor Islet Schwann Cells and Pericytes in Islet Transplantation and Graft Neurovascular Regeneration
por: Juang, Jyuhn-Huarng, et al.
Publicado: (2015) -
Downregulation of Signaling-active IGF-1 by Dipeptidyl Peptidase IV (DPP-IV)
por: Lin, Ching-Ting, et al.
Publicado: (2010) -
Tackling dipeptidyl peptidase IV in neurological disorders
por: Al-Badri, Ghaith, et al.
Publicado: (2018)